Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

234 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators. Jasmer RM, et al. Among authors: blumberg hm. Ann Intern Med. 2002 Oct 15;137(8):640-7. doi: 10.7326/0003-4819-137-8-200210150-00007. Ann Intern Med. 2002. PMID: 12379063 Clinical Trial.
Preventing the nosocomial transmission of tuberculosis.
Blumberg HM, Watkins DL, Berschling JD, Antle A, Moore P, White N, Hunter M, Green B, Ray SM, McGowan JE Jr. Blumberg HM, et al. Ann Intern Med. 1995 May 1;122(9):658-63. doi: 10.7326/0003-4819-122-9-199505010-00003. Ann Intern Med. 1995. PMID: 7702227
Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.
Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Tukvadze N, Little B, Bernheim A, Read TD, Guarner J, Derendorf H, Peloquin CA, Blumberg HM, Vashakidze S. Kempker RR, et al. Among authors: blumberg hm. Antimicrob Agents Chemother. 2017 May 24;61(6):e00226-17. doi: 10.1128/AAC.00226-17. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28373198 Free PMC article.
234 results